Table 2.

Scores of dyspeptic symptoms, quality of life, and mental status before and after the treatment.

Items	Groups	N	Baseline	After treatment	Difference	Improvement rate	P value
PF	Treatment	28	9.00 ± 2.09	1.57 ± 2.28	7.43 ± 2.47	82.56%	<0.0001
	Control	27	8.89 ± 2.39	6.22 ± 2.59	2.67 ± 1.88	30.03%	<0.0001
	IGC						<0.0001
ES	Treatment	19	9.74 ± 1.91	0.42 ± 1.43	9.32 ± 1.97	95.69%	<0.0001
	Control	21	8.43 ± 2.87	6.05 ± 2.52	2.38 ± 1.80	28.23%	<0.0001
	IGC						<0.0001
EP	Treatment	21	6.81 ± 2.23	0.48 ± 1.03	6.33 ± 2.31	92.95%	<0.0001
	Control	22	7.41 ± 3.02	6.32 ± 3.41	1.09 ± 1.82	14.71%	0.0078
	IGC						<0.0001
EBS	Treatment	16	6.31 ± 2.39	0.50 ± 1.55	5.81 ± 2.17	92.08%	<0.0001
	Control	17	6.71 ± 2.78	6.47 ± 3.00	0.24 ± 0.56	3.58%	0.25
	IGC						<0.0001
DSSS	Treatment	28	24.32 ± 8.28	2.50 ± 3.28	21.80 ± 8.24	89.72%	<0.0001
	Control	28	24.79 ± 7.48	19.40 ± 8.23	5.36 ± 3.29	21.62%	<0.0001
	IGC						<0.0001
SF-36	Treatment	28	52.50 ± 13.94	70.00 ± 12.54	17.00 ± 14.04	33.52%	<0.0001
	Control	28	54.00 ± 16.41	56.00 ± 13.42	2.88 ± 8.74	5.33%	0.0099
	IGC						<0.0001
SDS	Treatment	28	57.96 ± 9.55	45.60 ± 8.75	12.30 ± 9.89	21.33%	<0.0001
	Control	28	57.60 ± 11.84	54.00 ± 10.80	3.50 ± 5.92	6.07%	0.0002
	IGC						0.0005
SAS	Treatment	28	52.30 ± 10.48	42.30 ± 6.22	10.00 ± 10.22	19.11%	<0.0001
	Control	28	52.36 ± 9.67	52.20 ± 7.98	0.11 ± 4.89	0.21%	0.8533
	IGC						<0.0001

PF: postprandial discomfort; ES: early satiety; EP: epigastric pain; EBS: epigastric burning sensation; DSSS: dyspeptic symptom sum score; SF-36: short-form 36 questionnaire; SDS: Self-Rating Depression Scale; SAS: Self-Rating Anxiety Scale; IGC: intergroup comparison.